These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9324301)

  • 1. Expression of interleukin-6 receptors by pediatric acute lymphoblastic leukemia cells with the t(4;11) translocation: a possible target for therapy with recombinant IL6-Pseudomonas exotoxin.
    Gu L; Zhou M; Jurickova I; Yeager AM; Kreitman RJ; Phillips CN; Findley HW
    Leukemia; 1997 Oct; 11(10):1779-86. PubMed ID: 9324301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric acute myelogenous leukemia cells express IL-6 receptors and are sensitive to a recombinant IL6-Pseudomonas exotoxin.
    Boayue KB; Gu L; Yeager AM; Kreitman RJ; Findley HW
    Leukemia; 1998 Feb; 12(2):182-91. PubMed ID: 9519780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 fused to a mutant form of Pseudomonas exotoxin kills malignant cells from patients with multiple myeloma.
    Kreitman RJ; Siegall CB; FitzGerald DJ; Epstein J; Barlogie B; Pastan I
    Blood; 1992 Apr; 79(7):1775-80. PubMed ID: 1558971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human renal cell carcinoma cells are sensitive to the cytotoxic effect of a chimeric protein composed of human interleukin-4 and Pseudomonas exotoxin.
    Puri RK; Debinski W; Obiri N; Kreitman R; Pastan I
    Cell Immunol; 1994 Apr; 154(1):369-79. PubMed ID: 8131209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute myelocytic leukemia with interleukin-6 Pseudomonas exotoxin fusion protein in a rat leukemia model.
    Rozemuller H; Rombouts WJ; Touw IP; FitzGerald DJ; Kreitman RJ; Pastan I; Hagenbeek A; Martens AC
    Leukemia; 1996 Nov; 10(11):1796-803. PubMed ID: 8892684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Specific cytotoxicity of recombinant interleukin 6-pseudomonas exotoxin fusion protein (IL6-PE40) on LT12 leukemic cells expressing high levels of interleukin 6 receptor (IL6R)].
    Xi YZ
    Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):419-22. PubMed ID: 8200278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of IL6-PE4E, a recombinant fusion of interleukin 6 with Pseudomonas exotoxin.
    Kreitman RJ; Pastan I
    Bioconjug Chem; 1993; 4(6):581-5. PubMed ID: 8305530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity of IL6-PE40 and derivatives on tumor cells expressing a range of interleukin 6 receptor levels.
    Siegall CB; FitzGerald DJ; Pastan I
    J Biol Chem; 1990 Sep; 265(27):16318-23. PubMed ID: 2118904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-specific toxicity of a chimeric protein composed of interleukin-6 and Pseudomonas exotoxin (IL6-PE40) on tumor cells.
    Siegall CB; Nordan RP; FitzGerald DJ; Pastan I
    Mol Cell Biol; 1990 Jun; 10(6):2443-7. PubMed ID: 2160579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A wide range of human cancers express interleukin 4 (IL4) receptors that can be targeted with chimeric toxin composed of IL4 and Pseudomonas exotoxin.
    Debinski W; Puri RK; Kreitman RJ; Pastan I
    J Biol Chem; 1993 Jul; 268(19):14065-70. PubMed ID: 8314773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chimeric protein comprised of IL-4 and Pseudomonas exotoxin is cytotoxic for activated human lymphocytes.
    Puri RK; Mehrotra PT; Leland P; Kreitman RJ; Siegel JP; Pastan I
    J Immunol; 1994 Apr; 152(7):3693-700. PubMed ID: 8144944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of interleukin 6-Pseudomonas exotoxin chimeric molecules against the human hepatocellular carcinoma, PLC/PRF/5 in mice.
    Siegall CB; Kreitman RJ; FitzGerald DJ; Pastan I
    Cancer Res; 1991 Jun; 51(11):2831-6. PubMed ID: 1851660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein.
    Puri RK; Leland P; Kreitman RJ; Pastan I
    Int J Cancer; 1994 Aug; 58(4):574-81. PubMed ID: 8056454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective killing of IL6 receptor bearing myeloma cells using recombinant IL6-Pseudomonas toxin.
    Siegall CB; FitzGerald DJ; Pastan I
    Curr Top Microbiol Immunol; 1990; 166():63-9. PubMed ID: 2127396
    [No Abstract]   [Full Text] [Related]  

  • 15. [Molecular design and construction of IL6D24-PE40KDEL, a novel recombinant interleukin6-pseudomonas exotoxin fusion protein, having targeted cytotoxicity for leukemias expressing interleukin6 receptors].
    Zheng LY; Xi YZ; Kong FH; Cui JW; Liang F; Liu N; Sun YY; Guo SQ
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1246-50. PubMed ID: 12930640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human acute lymphoblastic leukemia line with the T(4;11) translocation as a model of minimal residual disease in SCID mice.
    Gobbi A; Di Berardino C; Scanziani E; Garofalo A; Rivolta A; Fontana G; Rambaldi A; Giavazzi R; Biondi A
    Leuk Res; 1997; 21(11-12):1107-14. PubMed ID: 9444945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation.
    Toren A; Novick D; Or R; Ackerstein A; Slavin S; Nagler A
    Transplantation; 1996 Jul; 62(1):138-42. PubMed ID: 8693533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells.
    Siegall CB; Schwab G; Nordan RP; FitzGerald DJ; Pastan I
    Cancer Res; 1990 Dec; 50(24):7786-8. PubMed ID: 2253221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by Pseudomonas exotoxin coupled to interleukin-13 and -4.
    Kornmann M; Kleeff J; Debinski W; Korc M
    Anticancer Res; 1999; 19(1A):125-31. PubMed ID: 10226533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
    Kioi M; Kawakami K; Puri RK
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6231-8. PubMed ID: 15448012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.